At The Medicines Company, we strive to improve health outcomes for patients, physicians and providers.
In the United States, we currently have one marketed product in the acute cardiovascular care area. To learn more about our U.S. marketed product, click here.
Additionally, we have marketing authorization for products in the European Union and other markets outside of the United States. To learn more about our various global marketed products and the countries where they are approved, click here.